Psoriasis Uncovered

Description: "What is metabolic disease and why do I have it on top of psoriatic disease?" Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation. Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3's, polyphenols, and fiber, to making small sustainable changes. This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach Danielle Cahalan. (1:27) Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis. (3:11) How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis. (6:54) The four pillars of health that can be used to reduce the risk of metabolic disease. (11:17) Does an anti-inflammatory diet exist? (13:46) What is the Mediterranean diet and the foods that are typically included. (16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease. (21:03) The three types of healthy fats – what they are, how they work, and where to find them. (24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods. (28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber. (30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation. (33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term. (37:43) Start with small habit changes and then build from there to have an impact on your metabolic health. Key Takeaways: · Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes. · What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline. · Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health. Guest Bios: Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders. Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with All Access Dietitians which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women's health and digestive support. Danielle's primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It's about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity. Resources: "Mediterranean Diet Pyramid: Guidelines for Healthy Eating" © 2009 Oldways Preservation and Exchange Trust www.oldwayspt.org and UCSF Weill Institute for Neurosciences Memory and Aging Center. DASH Eating Plan (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute) Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial. AMA Dermatology . Dec. 1, 2025 The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9.

After being diagnosed with psoriasis and psoriatic arthritis, finding a community that understood how life changed meant everything to Jody Quinn, Ben and Kathryn Rifenbark. Join host Alan Simmons as he addresses life with psoriasis and psoriatic arthritis before and after finding the National Psoriasis Foundation with 3 amazing volunteers – Jody Quinn, Ben and Kathryn Rifenbark. Hear their story from struggles with initial diagnosis, being an advocate for their own health care, to how they chose to become part of a community and help others with the disease to support the mission of the National Psoriasis Foundation. Being part of NPF truly changed their lives! This episode features how 3 volunteers changed their lives to navigate the challenges of being diagnosed with psoriatic disease to taking steps to help others in need and the mission of the National Psoriasis Foundation. Timestamps: · (0:00) Intro to Psoriasis Uncovered & guest welcome Jody Quinn, Ben and Kathryn Rifenbark. · (0:59) What life was like for Ben and Kathryn from diagnosis to finding a community through NPF. · (2:42) Facing psoriatic arthritis first and being undiagnosed for years was challenging for Jody. · (4:48) Finding control over psoriatic disease by becoming an advocate for change. · (6:15) Diving into the deep end to help fundraising efforts. · (7:03) Becoming a One to One mentor to help answer questions from others and share the positive impact NPF makes in our lives. · (8:52) Making connections to help raise awareness about psoriatic disease from resolutions to public service announcements and lighting bridges in NPF's colors -- orange and blue. · (10:40) Receiving the NPF Volunteer Innovator award and being a Psoriatic Ambassador Honoree. · (12:04) Benefits we received from attending the IMPACT Summit Volunteer Leadership Conference. · (15:11) Jody's single most life-changing event was attending the FDA Drug Development meeting. · (17:23) It's important to advocate for your own health care needs while continuing to learn from others and resources available through the NPF. · (19:14) Every step no matter how small or large makes an impact and is important. Key Takeaways: · Being diagnosed with psoriasis and psoriatic arthritis is a life-long journey which can be made easier by finding the right health care, education and resources, as well as a community that understands what it means to live with psoriatic disease. You are not alone. · You can take control over your disease by advocating for policy changes that affect all patients regardless of what chronic disease they may have. Let your voice be heard. · Every step you take no matter how small or large makes a difference – whether it's learning more about psoriatic disease, sharing your story, or participating as a volunteer. You can make an impact. Start your journey with NPF today! Become a volunteer. Guest Bios: Jody Quinn has a long history of involvement with NPF as a volunteer. She first became a volunteer in 2012 after seeking to connect with others who have psoriatic disease during a Walk event. She remembers meeting an inspirational group of volunteers. Wanting to learn more about her disease she attended More Than Skin Deep and Be Joint Smart events and served as a moderator. Continuing her path of involvement she attended Volunteer Conferences in Chicago and San Francisco. In 2016 she attended her first Capitol Hill Day followed by the FDA Patient Focused Drug Development (PFDD) meeting. Her involvement was so profound she remains an active advocate promoting research and legislation to enhance access to treatments and health care services. Jody has been so successful in promoting awareness about psoriatic disease, she was awarded the NPF Volunteer Innovator Award in 2017. In 2025 she was also named as the New England Soiree Psoriatic Ambassador Honoree for her impactful service and tireless advocacy. In her words, "I volunteer because it gives me some control over what often feels like a completely uncontrollable disease. It allows me to have a say in what is happening with my life and my disease, which I didn't have before. I also volunteer so that others don't have to go through the same long and difficult journey to diagnosis and treatment that I did." Kathryn & Ben Rifenbark discovered the NPF after many challenges with finding the right diagnosis for Ben's psoriasis. Through a local NPF Take ACTION event Ben quickly learned he wasn't alone in living with his disease, while Mom, Kathryn, gained as much information as she could. After the event, they soon became part of the NPF community with Ben serving as the 2024 Take ACTION Ambassador and a leading peer-to-peer fundraiser. He shared his story and a motivational message at last year's Take ACTION event to help encourage others to support the mission of the NPF. Ben is also an IMPACT Ambassador learning how to advocate for himself and has participated in the IMPACT Summit representing the amazing youth who are part of our NPF Community. Kathryn is now a mentor sharing what she's learned with other parents. Resources: Volunteer Spotlight: Jody Quinn May 1, 2025 Ambassador, Advocate and Mentor Advance Online December 11, 2025. (Ben & Kathryn Rifenbark) Her Nails Held the Secret to Her PsA Advance Online Updated September 29, 2025.

Hear leading dermatologist Dr. E. James Song and patient advocate Ana Rinck share their perspectives on the use of biosimilars to manage psoriasis and psoriatic arthritis. The use of biosimilars is growing with 24 currently on the market and more on the way for the treatment of psoriasis and psoriatic arthritis. What does this mean for you? Find out as we explore the use of biosimilars, the impact of interchangeability, what it's like switching to a biosimilar, and what questions to ask your health care provider with leading dermatologist and NPF Medical Board member Dr. E. James Song, Director of Clinical Research at Frontier Dermatology Partners, and patient advocate Ana Rinck who currently uses a biosimilar to treat her psoriasis and psoriatic arthritis. The intent of this episode is to offer an update on the use of biosimilars and to hear the experience of those who have used biosimilars to manage psoriatic disease. This episode is sponsored by Organon. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. E. James Song, Director of Clinical Research and Co-Chief Medical Officer, Frontier Dermatology, and patient advocate Ana Rinck, who presents her experience with using a biosimilar to treat psoriasis and psoriatic arthritis. (0:58) Definition of what is a biosimilar in comparison to a biologic which is also referred to as the original bio-originator or reference product. (3:10) What biosimilars are available and how they are used. (4:35) The term interchangeable and what it means for use of a biosimilar. (5:46) Ana's diagnosis to treatment options starting with use of topicals to ultimately use of a biosimilar. (7:57) Treatment discussion and choices when faced with diminishing effectiveness within a class of medications. Should a biosimilar be considered as an option? (9:50) Questions to consider when there's a change in treatment. (10:57) FDA announcement to simplify the development process for biosimilars and what that means for the future use of biosimilars. (13:55) What to consider when thinking of a biosimilar as a treatment option and where to find help when needed. (14:53) The hope and equity of access that biosimilars represent is here for the appropriate individual. Key Takeaways: · A biosimilar is an FDA-approved biologic product that behaves and functions like a brand biologic treatment which is also called the reference product or bio-originator. There are no clinically meaningful differences between biosimilars and their reference product. · The FDA has approved several biosimilars for the treatment of psoriasis and psoriatic arthritis. Some have been identified as interchangeable which means a biosimilar could be substituted for a reference product without a health care provider's approval pending state legislative rules. · Don't be afraid to ask questions or access resources to assist with preparing for a medication change should that change be initiated either by yourself, your healthcare provider, or your health insurance company. Guest Bios: E. James Song, M.D. is a nationally recognized dermatologist and clinical researcher who is also a Clinical Instructor at the University of Washington. Dr Song is recognized as a key opinion leader in treating psoriasis and atopic dermatitis. He is actively involved in the development of new therapies for dermatologic disease and has firsthand experience with treatments before they come to market. Dr. Song has been published extensively in peer review journals and regularly participates in meetings both as a lecturer and attendee. He is also a Medical Board member of the National Psoriasis Foundation. He believes that the best health outcomes come from shared decision making between the patient and physician. Dr. Song strives to help patients understand not only their condition, but all their treatment options. Ana Rinck is a patient advocate and volunteer for the National Psoriasis Foundation. She developed psoriasis in 2009 following symptoms she noticed for a few years which proved to be challenging to diagnose. She managed for many years on topicals and intralesional injections. In 2018 she was diagnosed with psoriatic arthritis and started use of a biologic realizing she needed to protect her joints from further damage. She now uses a biosimilar to manage her psoriatic disease. Ana owns her own private consulting business and is an Operations and Project Manager. Resources: -Learn more about biosimilars, interchangeability, and state substitution rules. -Armstrong A, Callis Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, Gladman D, Han G, Hawkes JE, Hsu S, Kircik L, Koo J, Kreuger GG, Lebwohl M, Leonardi C, Lewitt GM, Liao W, Liu C, Markenson J, Merola JF, Orbai A, Prussick R, Richardson V, Soung J, Van Voorhees AS, Wallace E, Weinberg J, Wine Lee L, Harris J, Koons S, Howard L. Position Statement on the Use of Biosimilars for Psoriasis and Psoriatic Arthritis. National Psoriasis Foundation Medical Board. 2023. -If you need help finding a dermatologist near you contact the NPF's Patient Navigation Center for assistance.

"Help! It's winter and my psoriasis and psoriatic arthritis is flaring." Listen as certified physician assistant Eileen Cheever offers tips to help manage psoriasis and psoriatic arthritis flares that occur during the winter months. Join host Corinne Rutkowski as she explores tips for managing psoriasis and psoriatic arthritis when cold weather flares the disease with Certified Physician Assistant Eileen Cheever from Clearview Dermatology. Listen as they discuss why flares occur and tips for improving flares from humidity, moisturizing products even for palmoplantar psoriasis, types of fabrics to layer, addressing aches and pains with psoriatic arthritis, use of rescue therapy, to stress and mood changes. This episode offers information to help address winter flares that may cause you to struggle with your psoriatic disease during cold weather. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome Certified Physician Assistant Eileen Cheever. (1:15) Definition of a psoriasis or psoriatic arthritis flare. (2:32) How cold weather could be connected to winter flares of psoriatic disease. (4:11) Tips for addressing dryness and lack of humidity in the home. (6:13) Products that help moisturize your skin and when is the best time to apply it to your skin. (8:56) Products for moisturizing the hands and feet with palmoplantar psoriasis. (12:33) Types of fabrics to layer in the winter to help decrease the itch while staying warm. (14:15) Tips for addressing the aches and pains that come with cold winter months. (16:22) Medication changes vs use of rescue therapy for treating a winter flare. (17:51) Tips to help manage overall health, stress, and mood. (21:37) Reach out to your health care provider if you are struggling with your psoriatic disease. Key Takeaways: · While we don't completely understand the connection, 4 out of 10 people identify winter as the season that flares their psoriasis. · Factors that contribute to cold weather flares include lack of moisture or humidity in the air, viruses or flu, long heated showers that lead to dry, itchy skin, itchy fabrics, stress, and depression with dark days. · Strategies to address winter flares include various moisturizing products, maintaining 60% humidity, choosing breathable fabrics, lifestyle choices, and keeping your dermatologist and rheumatologist informed should rescue therapy be needed. Guest Bio: Eileen Cheever is a certified dermatology physician assistant (PA-C) with a clinical practice at Clearview Dermatology where she treats adults and children with a variety of diseases of the skin, hair, and scalp including psoriasis. She is a diplomate member of the Society of Dermatology Physician Assistants, a founding advisory board member for Elevate Medical Education, a member of the American Academy of Physician Assistants, and a member of the NPF Advanced Practice Provider (APP) Advisory Committee. She has a passion for providing education and lectures frequently at dermatology conferences across the country. Resources: Seasonal Flares Guide. National Psoriasis Foundation 2023©. 8 Must-Have Lotions. Advance Weekly. Updated September 30, 2025. "Managing Chronic Pain with Psoriatic Arthritis" podcast episode addressing why pain occurs, its impact, and what can be done to manage pain both physically and emotionally.

Description: Psoriatic disease affects far more than just the skin. Hear leading dermatologist Dr. April Armstrong and Dr. Benoît Guérrette discuss this and more with Jensen, a patient advocate. Psoriatic disease affects not only the skin but it can impact confidence, emotional and social well-being, and daily life. In this episode, join moderator Dr. Guy Eakin, Chief Scientific and Medical Officer at NPF, as we explore the disconnect between clinical classifications of psoriasis and what patients experience in real-life with leading dermatologist Dr. April Armstrong, Dr. Benoît Guérrette, Vice President of Dermatology & Rheumatology at Takeda, and Jensen, a NPF patient advocate and former Lead Youth Ambassador. Listen as we address the need for a more nuanced approach to classifying disease severity that accounts for the holistic needs of psoriatic disease, as well as share insights into how advocacy and awareness can drive change in treatment access and care standards. The intent of this episode is to identify how clinical severity classifications of psoriasis are evolving to meet the needs of those who live with the disease and how that change impacts overall management. This episode is sponsored by Takeda. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. April Armstrong, Vice President of Takeda, Dr. Benoît Guérette, and patient advocate Jensen, who discuss the unmet needs of people with moderate psoriasis and how as a community we can better serve those living with the disease. 2:22 How health care providers and the biopharmaceutical industry are coming together to address systemic eligibility and the unmet needs of people living with psoriasis. 4:25 Quality of life should be included when assessing clinical severity in psoriasis and identification of appropriate treatment choices. 6:52 The impact of misdiagnosis, inappropriate treatment, and effect on high impact sites can be life- altering. 8:30 How appropriate treatment and knowledge can make all the difference when diagnosed with plaque psoriasis. 9:40 Views on the psoriasis disease classification system and how it's evolving to include real life impact from physical and emotional needs, to more personalized care for those living with psoriasis, even when small body surface areas are involved. Severity isn't defined by skin coverage alone. 12:38 What's needed to prioritize the care and outcomes of people living with psoriasis. 14:18 The future of management and care for psoriatic disease. 15:53 "My skin tells a story." Wisdom from what I wish I had known previously. 16:52 Moving closer to care that truly reflects the lives and needs of those who live with psoriasis. Key Takeaways: · Severity of psoriasis isn't defined by skin coverage or body surface area (BSA) alone. The impact on quality of life should also be considered in the assessment, selection of treatment, and management of the disease. · The psoriasis disease classification system is evolving to be more of a patient centered approach. Many clinicians are now using the International Psoriasis Council (IPC) or 2 bucket approach to identify whether someone should receive a topical or systemic treatment based on location and response to treatment, as well as impact on quality of life. · With continued research and development, the next 5 to 10 years could see a shift in effective treatment options while also treating sooner to initiate better outcomes for people living with psoriasis and psoriatic arthritis. Guest Bios: April Armstrong, M.D., M.P.H. is an internationally renowned dermatologist and clinical researcher who is a Professor and Chief of Dermatology at the University of California Los Angeles (UCLA) where she specializes in inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa (HS). Dr. Armstrong is also the Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. She has conducted over 150 clinical trials and published over 350 high impact articles in scientific journals. Dr. Armstrong holds multiple leadership positions including the immediate Past Chair of the National Psoriasis Foundation Medical Board, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Psoriasis Council, and board member for the International Dermatology Outcome Measures and the American Academy of Dermatology. Benoît Guérette, Ph.D. is an accomplished leader in medical affairs with extensive experience across academia and the pharmaceutical industry. Since March 2025, Dr. Guérette has served as Vice President of Dermatology and Rheumatology US Medical Affairs at Takeda Pharmaceutical. Prior to joining Takeda, he held several strategic and leadership roles at various pharmaceutical companies, including overseeing clinical development, global and U.S. medical affairs, global access & pricing, translational sciences and more. Before transitioning to the industry, Dr. Guérette was an Associate Professor of Immunology at Laval University, leading research in cancer immunology. He holds a Ph.D. in Medicine, Microbiology, and Immunology from Laval University and completed postdoctoral studies in Inflammation and Immunology at Harvard Medical School. Jensen is a volunteer and former Lead Youth Ambassador for the National Psoriasis Foundation. Jensen developed psoriasis at age 7 but wasn't formally diagnosed until age 14 being misdiagnosed along the way, trying different management approaches that were ineffective. She was a competitive swimmer from elementary through high school and in the last 2 years of high school played lacrosse. Upon finishing high school she attended college becoming a registered nurse in an intensive care unit. Jensen wants "youth living with psoriatic disease to feel a community that is behind them and with them every step of the way. I really want to be able to make a difference in a way that would've helped me as a child when I was diagnosed." Resources: Ø "Reassessing Psoriasis Severity" Advance Online, National Psoriasis Foundation. H. Onorati. January 16, 2024, https://www.psoriasis.org/advance/psoriasis-severity-high-impact-sites/ Ø "Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities". Blauvelt, A., Strober, B., Gondo, G., Journal of Psoriasis and Psoriatic Arthritis Volume 8, Issue 3. https://journals.sagepub.com/doi/full/10.1177/24755303231160683

Description: In this episode, we'll explore what it means to aim for no compromise in psoriatic arthritis care—addressing both skin and joint symptoms with dermatologist and rheumatologist Dr. Saakshi Khattri and patient advocate Dayna Pham who lives with psoriasis and psoriatic arthritis. Join moderator Jeff Brown as he asks how patients and their healthcare providers can work in partnership to create a comprehensive, personalized treatment plan that reflects the full impact of psoriatic disease with triple board-certified dermatologist, rheumatologist, and internist Dr Saakshi Khattri, who is also an NPF medical board member, along with Dayna Pham, a patient advocate and volunteer with NPF's advocacy and community engagement teams who is living with psoriasis and psoriatic arthritis. . Whether you're newly diagnosed or navigating long-term care, this conversation is all about advocating for care that supports your whole self—without settling for less. The intent of this episode is to emphasize the need to be aware of psoriatic arthritis symptoms and once symptoms are present accept no compromise when treating skin and joints to obtain clear skin and painless joints. This podcast episode is sponsored by UCB. Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist, rheumatologist, and internist Dr. Saakshi Khattri and Dayna Pham, a patient advocate and medical student living with plaque psoriasis and psoriatic arthritis. (1:38) Psoriasis is more than skin deep with an inflammatory connection between the skin and joints. (3:03) The onset of psoriatic arthritis can be confusing. Healthy skin and joints should be the expectation without having to compromise on life's goals. (4:16) Knowing the association between psoriasis and psoriatic arthritis from the beginning is important to avoid delay in diagnosis and treatment. Be aware of systemic symptoms and discuss risks with a health care provider. (6:18 ) The goal of treatment is to achieve meaningful and lasting improvement in skin and joint symptoms. (7:56) Treatments have evolved to target known drivers of inflammation in psoriasis and psoriatic arthritis. (8:29) The IL-17 family is a key cytokine with 6 related signaling molecules. IL-17A and F play a role in the inflammatory process related to psoriasis and psoriatic arthritis. (9:48) What discussion about treatment goals could include between a patient and health care provider. (13:19) If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and find a treatment that offers no compromise on achieving clear skin and healthy joints. Key Takeaways: · Psoriasis is an immune mediated disease that results in systemic inflammation that can affect both the skin and joints. Unfortunately many people do not realize their joint symptoms may be related to their psoriasis. · The purpose of treatment which uses a variety of mechanisms of action targeting specific cytokines such as TNF-alpha, IL-12/23, IL-23, IL-17 is to achieve meaningful and lasting improvement in skin and joint symptoms. · If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and to work with your health care team to identify goals and treatment choices that aim to preserve quality of life. Guest Bios: Saakshi Khattri, M.D., MAS, is a triple board certified medical dermatologist, rheumatologist, and internist in the greater New York area who serves on the medical board of the National Psoriasis Foundation. She is the Director of the Center for Connective Tissue Diseases at Icahn School of Medicine at Mount Sinai. Dr. Khattri's area of interests include inflammatory and autoimmune skin diseases especially those with a rheumatology/dermatology overlap like psoriasis and psoriatic arthritis. She is actively involved in research and clinical trials for psoriasis and psoriatic arthritis where she seeks to identify immune pathways that lead to new biomarkers and treatments. Dr. Khattri is extensively published in peer reviewed journals and is also a member of the International Psoriasis Council. ​Dayna Pham is a patient advocate, medical student, and volunteer with NPF's advocacy and community engagement teams who lives with psoriasis and psoriatic arthritis. Dayna's psoriasis journey began at age 21 when she discovered bumps on her back which became plaques. Within weeks her body was impacted head to toe with plaque psoriasis, at 40% BSA. After being misdiagnosed and undertreated for a few months she eventually found a dermatologist who diagnosed her with moderate-to-severe plaque psoriasis and prescribed a biologic. She's 25 now and seeks to live her fullest life possible while balancing her psoriasis and psoriatic arthritis. Resources: · Learn more about psoriatic arthritis from symptoms, diagnosis, treatment options to coping with the disease. Ø · Armstrong A, Levit NA, Schneider B, et al. Patient-identified treatment goals for psoriatic disease: Results from a US patient survey. J Psoriasis Psoriatic Arthritis. 2025;10(1):1–11.

Episode Description: Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication? Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments. Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines. (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances. (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don't be afraid to ask questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: · Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines. · Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics. · It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist. Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources: "Does Having Psoriatic Disease Impact Vaccine Choices?" Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania). Medical Board Clinical Statements

Dermatologist Dr. Erin Boh and patient advocate Brian Lehrschall discuss the challenge of managing weight, psoriasis, and psoriatic arthritis which share common inflammatory pathways and what can be done to improve all together. Join moderator Jennifer Bomberger as she asks what is the connection between psoriatic disease and excess weight and what can be done to counter the effects of inflammatory cytokines for both with leading dermatologist Dr. Erin Boh and Brian Lehrschall who has lost over 100 pounds using diet, exercise and a GLP-1 receptor agonist. Hear Brian's story along with what is a GLP-1, how they work, and side effects. The intent of this episode is to offer knowledge and an example of how a GLP-1 can be used successfully to improve the outcomes and management of psoriasis and psoriatic arthritis. This episode is sponsored by Lilly. A Word of Warning This episode contains information about the body, like body size, weight management, healthy eating, and lifestyle changes. If you have a history of disordered eating or are struggling with body-related mental health challenges, you might wish to explore some of our other helpful tools. There are clinical terms used by our speakers about body size or body weight that you might find triggering. Key among them is the word 'obesity.' While it is the scientifically correct name for a disease and a common clinical term, NPF acknowledges that this word is triggering and problematic, and it is used only for the clearest of accuracy. Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Erin Boh and Brian Lehrschall, who has been living with psoriatic disease for over 30 years and has recently lost over 100 pounds. (1:32) Health challenges Brian faced while trying to manage his weight, psoriasis, and psoriatic arthritis. (4:08) Many factors contribute to psoriasis, psoriatic arthritis, and comorbidities. (5:56) Discussing the sensitive subject of losing weight and changing lifestyle. (7:57) The inflammatory pathways and connection between excess weight and psoriatic disease. (14:50) Tips for managing multiple diseases like psoriatic disease, depression, and excess weight together. Realize "it's not your fault". (21:32) Are low calorie or anti-inflammatory diets effective with psoriasis? (25:21) The definition of a GLP-1 (receptor agonist), how they work, and benefits in resetting how the body functions. (30:02) Brian's experience and impact of using a GLP-1. (32:08) Current and future use of GLP-1 in the management of psoriatic disease, comorbidities, and excess weight. (34:49) Be an advocate for yourself to help do all the things that will make you feel better about living with psoriasis and psoriatic arthritis. Key Takeaways: · Obesity or excess weight is a disease driven by an overproduction of inflammatory cytokines. · Psoriasis, psoriatic arthritis, and excess weight have shared pro-inflammatory disease pathways that should be considered together when identifying an effective treatment plan. · GLP-1 receptor agonists can be used along with dietary changes and exercise to induce weight loss that improves the body's reaction to medications used to treat psoriasis and psoriatic arthritis. Guest Bios: Erin Boh, M.D., Ph.D. is the Joseph Chastain Endowed Chair of Clinical Dermatology at Tulane University, School of Medicine where she is also a Professor and Chairman of Dermatology. Her clinical and research focus includes photobiology, chronic diseases such as psoriasis, psoriatic arthritis, and skin cancers such as lymphoma. Dr. Boh is a past Medical Board member of the National Psoriasis Foundation and is currently a President's Council Member which represents an elite group of health care providers who are committed to the mission of the Foundation and finding a cure for psoriasis. Dr. Boh has published many articles including addressing today's topic about weight management and inflammation in psoriasis. Brian Lehrschall has lived with psoriatic disease for three decades. He was first diagnosed with psoriasis about thirty years ago, at the age of 13 and with psoriatic arthritis at age 15. With the diagnosis came bullying which led to emotional eating. Per Brian "The more I ate, the worse the weight got." Like most people who are overweight Brian tried to improve his health with diet and exercise. Along the way he learned about the connection between psoriasis and excess body weight. Eventually a physician recommended he try the weight loss medication GLP-1 (Glucagon-like peptide-1). Using this medication he has lost over 100 pounds and is still losing weight along with improving his overall health which includes his psoriasis and psoriatic arthritis. Brian joined the National Psoriasis Foundation in 2000 as a volunteer and has become an advocate for improving access to care and sharing his story about living with psoriatic disease. Resources: Ø "Taking Back Control" Advance Online. M. Werbach. July 17,2025. Ø "Is Choosing the Mediterranean Diet Right For You and Your Psoriatic Disease?" podcast episode with dermatologist Dr. Adam Ford and registered dietitian, Danielle Baham. Ø Find the support you need through the One to One Program

Pediatric rheumatologist Dr. Pamela Weiss speaks with Michael and his 12 year old daughter Ava about navigating the challenge of living with psoriasis and psoriatic arthritis together as a family. Join moderator Kaleigh Welch as she discusses the challenges of living with psoriasis and juvenile psoriatic arthritis (JPsA) from diagnosis, misconceptions about psoriatic disease, to management and treatment with pediatric rheumatologist, Dr. Pamela Weiss from Children's Hospital of Philadelphia, Division of Rheumatology, along with Michael and Ava, whose psoriatic disease is truly a family affair. The intent of this episode is to raise awareness about the complexities and nuances associated with living with psoriasis and psoriatic arthritis as a child or an adult and not letting the disease stop you from doing what you love to do. This episode is sponsored by Amgen. Mike, Ava, and Dr. Weiss were compensated for their time. Timestamps: · (0:00) Intro to Psoriasis Uncovered and guest welcome pediatric rheumatologist Dr. Pamela Weiss, Michael and Ava Sayles who both have been diagnosed with psoriasis and psoriatic arthritis. · (1:28) What the psoriatic disease diagnosis process could be like for children and adults. · (5:34) Misconceptions associated with psoriasis leading to delayed diagnosis of psoriatic arthritis. · (7:36) What people misunderstand about plaque psoriasis and psoriatic arthritis. · (11:06) Challenges to finding the right treatment while living life with psoriatic disease. · (17:24) What drives treatment choices for psoriatic disease in youth. · (19:59) Assessing what's most important in reaching treatment goals. · (23:57) What the future holds for management of Juvenile Psoriatic Arthritis (JPsA). · (26:10) Living with psoriatic disease is challenging but find what's right for you and don't give up on what you love to do. Key Takeaways: · Diagnosis of plaque psoriasis and psoriatic arthritis can be challenging given subtleties that can occur in the presentation of the disease in adults and children. · There are a variety of treatments that work either alone or in combination to treat plaque psoriasis and psoriatic arthritis with choice of treatment dependent on what is the primary goal for the individual's physical and emotional health. · The future is bright as understanding of the disease increases and treatment options expand and become more targeted to more effectively address skin and joint issues associated with psoriatic disease. Guest Bios: Pamela Weiss, M.D., MSCE, is a pediatric rheumatologist and the Clinical Research Director of the Division of Rheumatology at Children's Hospital of Philadelphia. Dr. Weiss is also the Distinguished Endowed Chair in the Department of Pediatrics. She has advanced training in clinical epidemiology with a focus on early diagnosis, and targeted treatment of children with spondyloarthritis (SpA). Dr. Weiss is also a Professor of Pediatrics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is a member of the American Academy of Pediatrics, American College of Rheumatology, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Spondylitis Association of America, and the SPondyloArthritis Research & Treatment Network (SPARTAN). Michael and Ava Sayles, psoriatic disease is a family affair. Both father and daughter, successfully navigate living with plaque psoriasis and psoriatic arthritis. Michael or Mike was diagnosed in his twenties, and Ava at age 7 and then later on juvenile psoriatic arthritis. She is now 12 years old. They have experienced issues with diagnosis, and a long journey of finding treatment options that worked for them. Mike found the best solution was establishing a routine or rhythm of treatment around work and school to avoid flare-up's if possible, saying "keeping on top of what you need to do for the psoriasis and the arthritis becomes a big part of your life". Resources: Our Spot: What is Psoriatic Arthritis

Hear Christopher McKim's journey with moderate to severe plaque psoriasis and the latest clinical trial results from dermatologist, Dr. Christine Cornejo. Join this discussion with moderator Archie Franklin as Christopher McKim, a BMS employee living with moderate to severe plaque psoriasis, and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS, offer a patient and physician's perspective on treating plaque psoriasis from the inside. Listen as Chris presents his journey along with Dr. Cornejo addressing effectiveness and safety information with clinical trial results for a prescription oral treatment option. The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment option that is right for them. This episode is sponsored by Bristol Myers Squibb. For more information view Full Prescribing Information and Medication Guide . · (0:00) Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb. · (2:15) Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began. · (3:09) The decision by Chris and his provider to try an oral systemic medication. · (3:28) The effects and impact of an oral systemic treatment for Chris and his plaque psoriasis. · (4:09) Dr. Cornejo addresses efficacy and clinical trials results. · (5:58) Common side effects and safety concerns for the treatment Chris and his health care provider decided to try. · (6:28) Health considerations patients and providers should discuss prior to using a systemic treatment. · (6:54) What to do should side effects occur. · (7:10) How Chris feels with clearer skin after making a change in treatment. · (8:14) Indication and Important Safety Information. Key Takeaways: · Moderate to severe plaque psoriasis is a systemic disease. · If you're ready to treat from the inside there is a treatment option that may help. · Work with a health care provider to find the right treatment for moderate to severe plaque psoriasis. · Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for plaque psoriasis. Guest Bios: Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division. Prior to joining BMS, Chris worked at Sanofi, J&J, Leo Pharma, and Sun Pharma in various field and home office roles. Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding). Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students. Resources: Current Oral Systemic Treatments For additional questions about treatment options contact the NPF Patient Navigation Center

Join us to hear Jennifer's incredible unexpected journey from mysterious, itchy skin blotches leading to a full psoriasis diagnosis and how she found the right treatment for her with dermatologist Dr. Christina Feser and Mind.Px. Listen as Jennifer tells her diagnostic odyssey from itchy, skin blotches to psoriasis with host Max Blitstein as together they explore her journey from topical treatments to biologics, and the emotional toll this disease can take. Learn how this psoriasis patient found relief with Dr. Christina Feser through the use of new precision medicine technology to find the right treatment for her. This episode highlights the importance of proactive care and the life-changing impact of finding the right medical support. Timestamps: · (0:00) Intro to Psound Bytes™ and guest welcome dermatologist Dr. Christina Feser and her patient Jennifer Kirsch. · (1:26) Jennifer's life prior to her diagnosis journey with psoriasis. · (2:29) Symptoms, diagnosis, and initial treatment course. · (4:26) The path to taking control of Jennifer's psoriasis begins with a Mind.Px test. · (9:15) Timeline for the Mind.Px test results and how it felt to get the test. · (12:14) Implementation and results of the treatment recommended by Dr. Feser and the Mind.Px test. · (17:22) The emotional impact of living with psoriasis. · (19:24) Be proactive when something is not right. Listen to your body. · (19:57) Getting on the right medicine initially has value. · (21:16) While the journey is not easy, taking advantage of available technology offers better management of patients with psoriasis. 3 Key Takeaways: · Diagnosis of psoriasis can be challenging but it all starts with finding the right health care provider who listens to you as a patient. · Technology now exists through Mind.Px to help providers and patients select a therapy that is more biologically appropriate to manage their psoriasis. · Be proactive in taking steps to ensure you receive the right treatment for you and your health. Guest Bios: Dr. Christina Feser is a board-certified dermatologist with Nashville Skin, a comprehensive dermatology center for adults and children where she specializes in the latest medical treatments for skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She has a passion for research, serving as Principal Investigator on numerous clinical trials with a focus on psoriasis, eczema, alopecia, vitiligo, and other skin diseases. She is a fellow of the American Academy of Dermatology, the American Osteopathic College of Dermatology, and is a member of the Nashville Dermatology Society and the Tennessee Dermatology Society. Jennifer Kirsch, a patient of Dr. Feser's, was diagnosed with psoriasis in November 2024 after initially being diagnosed with eczema. Taking matters into her own hands, Jennifer not only found the right care with Dr. Feser, but also the right treatment to help her live her life without the itch associated with psoriasis. Resources: Ø Current Biologics on the Market https://www.psoriasis.org/current-biologics-on-the-market/ Ø Mindera Health – Shaping the Era of Digital Predictive Skin Analytics https://minderahealth.com

Have a red, painful eye that's sensitive to light? Could be uveitis. Hear ophthalmologist Dr. Timothy Janetos discuss uveitis and how it relates to psoriasis and psoriatic arthritis. Join host Takieyah Mathis for an eye opening discussion about uveitis, cataracts, and eye health with ophthalmologist Dr. Timonthy Janetos from Northwestern Medicine, Department of Ophthalmology. Listen as they discuss what is uveitis and cataracts from key symptoms, the significance of the HLA-B27 marker, diagnosis, to treatment options that help reduce inflammation and preserve long term vision. This episode offers information to help you advocate for your eye health by recognizing when you need help from an ophthalmologist and what actions you can take to reduce your risks associated with uveitis. Timestamps: · (0:00) Intro to Psound Bytes & guest welcome ophthalmologist Dr. Timothy Milton Janetos. · (1:21) Definition of uveitis and the relationship to psoriatic disease. · (5:35) Symptoms of uveitis. · (7:45) How uveitis is diagnosed. · (9:24) Treatment options for uveitis. · (13:11) What happens if eye injections are needed as treatment. · (14:47) Association between inflammation, psoriatic disease, and cataracts. · (15:48) Symptoms of a cataract. · (16:33) Treatment for cataracts. · (21:11) New advancements in treating uveitis and cataracts. · (25:50) General eye health actions to help reduce risks associated with inflammation. Early detection is key. 4 Key Takeaways: · Uveitis is a huge spectrum of different diseases with about half of the associations due to chronic, immune related diseases like psoriasis or psoriatic arthritis. · If you wake up with a red, painful eye that's sensitive to light, seek help from an ophthalmologist right away to minimize risk of scar tissue formation. · Work with a health care team to treat all aspects of psoriatic disease to reduce inflammation whether it's in the skin, joints, and/or the eye. · Lifestyle changes such as stop smoking and yearly eye exams are actions that can help reduce inflammatory factors and maintain overall eye health. Guest Bio: Dr. Timothy Milton Janetos is a board-certified and nationally recognized ophthalmologist with Northwestern Medicine, Department of Ophthalmology who specializes in uveitis and cataract surgery. He is also an Assistant Professor at the Feinberg School of Medicine, Department of Ophthalmology. Dr. Janetos offers comprehensive care using a personalized treatment plan for both children and adults with intraocular inflammation and infections. He is a professional member of the American Uveitis Society (AUS) and the Association for Research in Vision and Ophthalmology (ARVO), as well as the Editor for Frontiers in Ophthalmology and an Editorial Board Member for Annals of Eye Science. Resources: Ø Psoriatic Arthritis and Uveitis: What's it All About? Podcast with rheumatologist and ophthalmologist Dr. James Rosenbaum. (Released in 2019.) https://www.psoriasis.org/watch-and-listen/psoriatic-arthritis-and-uveitis-whats-it-all-about-psa/ Ø Eye Inflammation and Psoriatic Arthritis https://www.psoriasis.org/advance/eye-inflammation-and- psoriatic-arthritis/

Not sure what Minimal Disease Activity or MDA is and how it relates to psoriatic arthritis and your joints? Listen as rheumatologist Dr. Arthur Mandelin explains what MDA means. Join hosts Jeff Brown and LB Herbert as they discuss minimal disease activity in psoriatic arthritis with nationally recognized rheumatologist Dr. Arthur Mandelin who identifies what it is, factors that influence achieving MDA, how long it takes to reach, and the impact on selection of treatments. Dr. Mandelin also addresses fatigue associated with inflammation, and what the future holds for minimal disease activity in psoriatic arthritis. Whether you have psoriasis or psoriatic arthritis, this episode offers information to help you understand management goals set by your doctor and the importance of attaining minimal disease activity. Timestamps: (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Arthur Mandelin (02:23) What is minimal disease activity (MDA) (04:32) MDA in comparison to ACR response criteria (07:36) Criteria for reaching MDA (09:20) Positive and negative factors of MDA (11:25) Importance of reaching MDA within a specific time frame (17:34) Length of time to reach MDA (18:48) Selection of treatment options and psoriatic arthritis domains (23:51) Inflammation and fatigue (26:59) A look at the future of minimal disease activity in psoriatic arthritis: Reaching ACR 90 (29:09) Advancements in psoriatic arthritis: Finding disease markers (33:40 ) If you have psoriasis, be aware of your risk for psoriatic arthritis 4 Key Takeaways: There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life. Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes. Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized. Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help. Guest Bio: Dr. Arthur Mandelin is an Associate Professor of Medicine at Northwestern University Feinberg School of Medicine and the Department of Medicine Division of Rheumatology. Dr. Mandelin launched Northwestern University's first training program in musculoskeletal ultrasonography for rheumatology fellows. He is an active participant in the REASON Group which is a multi-center research collaboration devoted to using ultrasound guidance to obtain minimally invasive synovial tissue biopsies. Dr. Mandelin is a past member of the National Psoriasis Foundation's Medical Board where he served on consensus panels for the development of a variety of practice guidelines. Resources Mentioned: National Psoriasis Foundation: https://www.psoriasis.org PEST Screener: https://www.psoriasis.org/psoriatic-arthritis-screening-test/ PsA Action Month 2025: https://www.psoriasis.org/psa-action-month/ NSAIDS for Psoriatic Disease: https://www.psoriasis.org/advance/nsaids-for-psoriatic-disease-psa/ AMP (Accelerated Medicines Partnership): https://www.psoriasis.org/advance/progress-and-success- through-collaboration/ Tags: psoriasis, skin, psoriatic arthritis, minimal disease activity, ACR20, ACR50, ACR70, tender joints, bone erosion, joint swelling, enthesitis, inflammation, pain, fatigue, axial disease, spinal involvement, treatment, NSAIDS, biologics, personalized medicine, dermatology, National Psoriasis Foundation, AMP, Psound Bytes podcast, Soundbites podcast